Korro Bio, Inc. Public Float
Korro Bio, Inc. (KRRO) had Public Float of $88.97 million as of 2025-06-30, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-12
- 2025-06-30: Entity Public Float $88.97M.
- 2024-06-30: Entity Public Float $236.76M.
- 2023-06-30: Entity Public Float $12.15M.
- 2022-06-30: Entity Public Float $46.80M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $88.97M 10-K · filed 2026-03-12 |
| 2024-06-30 | $236.76M 10-K · filed 2025-03-18 |
| 2023-06-30 | $12.15M 10-K · filed 2024-03-26 |
| 2022-06-30 | $46.80M 10-K/A · filed 2023-05-01 |
| 2021-06-30 | $306.00M 10-K · filed 2022-03-15 |
| 2020-06-30 | $625.80M 10-K · filed 2021-03-29 |
| 2019-06-30 | $0.00 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |